U.S. is extending Covid public health emergency through spring 2023, administration official says

U.S. is extending Covid public health emergency through spring 2023, administration official says


Secretary of Health and Human Services Xavier Becerra answers questions during a Senate Health, Education, Labor, and Pensions Committee hearing to discuss reopening schools during the coronavirus disease (COVID-19) at Capitol Hill in Washington, D.C., September 30, 2021.

Greg Nash | Pool | Reuters

The U.S. is extending the Covid public health emergency through the spring of 2023, a Biden administration official said on Friday.

The decision to extend emergency comes as public health officials are expecting another Covid surge this winter as people gather more indoors where the virus spreads easier. The future also remains uncertain as more immune evasive omicron subvariants become dominant in the U.S.

The Health and Human Services Department previously extended the public health emergency until January. HHS Secretary Xavier Becerra has promised to give health-care providers 60 days notice before lifting the emergency declaration so they can prepare for a return to normal operations.

HHS did not send that notice out on Friday, the deadline, which means the emergency has been extended through the spring, the administration official said. How the U.S. fares against Covid this fall and winter will help determine whether the emergency needs to be renewed again moving forward, Becerra told reporters in October.

The public health emergency, first declared in January 2020 and renewed every 90 days since, has had a vast impact on the U.S. health-care system. The declaration has dramatically expanded public health insurance through Medicaid and the Children’s Health Insurance Program. Enrollment in these programs increased 26% during the pandemic to a record of more than 89 million people as of June.

HHS has estimated that as many as 15 million people could lose Medicaid or CHIP once the programs return to normal operations.

The emergency declaration has also given hospitals and other health-care providers more flexibility in how they operate.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Health

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]

Read More
Eli Lilly to build  billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Health

Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs

Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images) Raquel Natalicchio | Houston Chronicle | Getty Images Eli Lilly on Tuesday said it will spend […]

Read More
A biotech stock for investors scared to invest in the risky industry
Health

A biotech stock for investors scared to invest in the risky industry

Citigroup thinks investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the biotech stock at a buy rating and price target of $270, implying upside of 46% from Ligand’s Monday closing price of $184.67. Shares have soared nearly 79% this year. LGND YTD mountain LGND YTD chart […]

Read More